Evidence map›Paper›PMID 41122582›Full record

ArticleCureus2025

Elevating Research Transparency in Ayurveda: Editorial Insights on the Consolidated Standards of Reporting Trials (CONSORT) 2025.

Satyajit P Kulkarni, Pallavi S Kulkarni, Sachin S Chandaliya, Sainath B Sitawar, Naresh Nimbalkar

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Satyajit P KulkarniPanchakarma, Manjushree Research Institute of Ayurvedic Science, Gujarat Ayurved University, Gandhinagar, IND.
Pallavi S KulkarniAgadtantra, Manjushree Research Institute of Ayurvedic Science, Gujarat Ayurved University, Gandhinagar, IND.
Sachin S ChandaliyaPanchakarma, Shri Ayurved Mahavidyalaya, Nagpur, Maharashtra University of Health Sciences, Nashik, IND.
Sainath B SitawarRasashastra, Bhaisaheb Sawant Ayurved Mahavidyalaya, Maharashtra University of Health Sciences, Nashik, IND.
Naresh NimbalkarKayachikitsa, Chhatrapati Shahu Maharaj Shikshan Sanstha (CSMSS) Ayurved Mahavidyalaya, Aurangabad, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The release of the novel Consolidated Standards of Reporting Trials (CONSORT) 2025 and Animals in Research: Reporting In Vivo Experiments (ARRIVE) guidelines signifies a transformative shift in the landscape of clinical trial reporting. For the fields of Ayurvedic and herbal medicine, these revisions present a structured framework poised to enhance transparency, reproducibility, and global credibility in research. This editorial aims to delineate the key updates introduced within the revised CONSORT and ARRIVE frameworks and discuss their critical implications for the conduct and reporting of Ayurvedic research. The editorial underscores the imperative of seamless protocol integration, reinforced ethical clarity, and widespread academic adoption of these updated guidelines within the Ayurvedic research community.

Indexed as

arriveayurvedaclinical trial reportingconsort guidelinesresearch transparencyspirit guidelines

Identifiers

PMID41122582
PMCPMC12535846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.